Skip to Main Content.
Site navigation
Fidelity.com Home
  • Customer Service
  • Profile
  • Open an Account
  • Virtual Assistant
  • Log In
  • Customer Service
  • Profile
  • Open an Account
  • Virtual Assistant
  • Log Out
  • Accounts & Trade
    • Portfolio Log In Required
    • Portfolio
    • AccountPositions Log In Required
    • AccountPositions
    • Trade Log In Required
    • Trade
    • Trading Dashboard Log In Required
    • Trading Dashboard Log In Required
    • Active Trader Pro
    • Transfers
    • Cash Management Log In Required
    • Cash Management
    • Bill Pay Log In Required
    • Bill Pay
    • Full View Log In Required
    • Full View
    • Security Settings Log In Required
    • Security Settings
    • Account Features Log In Required
    • Account Features
    • Statements Log In Required
    • Statements
    • Fidelity Alternative Investments Program Log In Required
    • Tax Forms & Information
    • Retirement Distributions Log In Required
    • Fidelity Rewards+registered trademark Log In Required
    • Fidelity Rewards+registered trademark Log In Required
    • New Account Checklist Log In Required
    • Lending Solutions-Line of Credit Log In Required
    • Refer a Friend
  • Planning & Advice
    • What We Offer
    • Build Your Plan
    • My Goals
    • Financial Basics
    • Building Savings
    • Robo Investing Plus Financial Advice
    • Wealth Management
    • Find an advisor
    • Retirement
    • Life Events
    • Saving & Investing for a Child
    • Charitable Giving
  • News & Research
    • News
    • Wealth Management Insights
    • Watch List Log In Required
    • Quotes
    • Quotes
    • Alerts Log In Required
    • Mutual Funds
    • Stocks
    • Fixed Income, Bonds & CDs
    • ETFs
    • Options
    • Markets & Sectors
    • IPOs
    • Annuities
    • Learning Center
    • Notebook
    • Notebook
  • Investment Products
    • Mutual Funds
    • Retirement & IRAs
    • Stocks and Trading
    • Crypto
    • Direct Indexing
    • Fixed Income, Bonds & CDs
    • ETFs
    • Options
    • Sustainable Investing
    • Cash Management & Credit Cards
    • Managed Accounts
    • 529 College Savings
    • Health Savings Accounts
    • Annuities
    • Life Insurance & Long Term Care
  • Why Fidelity
    • The Fidelity Advantage
    • Planning & Advice
    • Trading
    • Straightforward Pricing
    • Insights & Tools
    • Security & Protection
    • Marketplace Solutions
    • About Fidelity
    • Careers
  • Customer Service
  • Profile
  • Open an Account
  • Virtual Assistant
  • Log In
  • Customer Service
  • Profile
  • Open an Account
  • Virtual Assistant
  • Log Out
Content and data provided by various third parties and Fidelity − Terms of Use
  • Research >
  • Stocks >
  • News & Events >

Stock Details


  • Snapshot
  • Detailed Quote
  • Advanced Chart &
    Technical Analysis Opens in New Window
  • News & Events
  • Compare
  • Analyst Opinions
  • Research Reports
  • Key Statistics
  • Earnings
  • Dividends
  • Ownership & Insiders
  • Financial Statements
  • SEC Filings

RELATED RESOURCES

  • Stock Research Overview
  • Stock Screeners
  • Markets & Sectors
  • Fidelity Learning Center Opens in New Window
Print Format
Change Text Size:
  • Default text sizeA
  • Larger text sizeA
  • Largest text sizeA

Benzinga's Top Ratings Upgrades, Downgrades For May 6, 2022

BY Benzinga
— 10:02 AM ET 05/06/2022

Upgrades

For Coupang Inc NYSE:CPNG, JP Morgan upgraded the previous rating of Neutral to Overweight. The stock has a 52-week-high of $46.00 and a 52-week-low of $11.91. At the end of the last trading period, Coupang closed at $11.99.

According to Guggenheim, the prior rating for NextGen Healthcare Inc NASDAQ:NXGN was changed from Neutral to Buy. In the third quarter, NextGen Healthcare showed an EPS of $0.24, compared to $0.26 from the year-ago quarter. The stock has a 52-week-high of $21.87 and a 52-week-low of $13.64. At the end of the last trading period, NextGen Healthcare closed at $19.52.

According to CLSA, the prior rating for Melco Resorts and Entertainment Ltd NASDAQ:MLCO was changed from Outperform to Buy. For the first quarter, Melco Resorts and Enter had an EPS of $0.37, compared to year-ago quarter EPS of $0.44. The stock has a 52-week-high of $19.18 and a 52-week-low of $5.12. At the end of the last trading period, Melco Resorts and Enter closed at $5.19.

Raymond James upgraded the previous rating for Jounce Therapeutics Inc NASDAQ:JNCE from Outperform to Strong Buy. Jounce Therapeutics earned $0.72 in the first quarter, compared to $0.58 in the year-ago quarter. The current stock performance of Jounce Therapeutics shows a 52-week-high of $9.81 and a 52-week-low of $4.79. Moreover, at the end of the last trading period, the closing price was at $4.86.

B of A Securities upgraded the previous rating for EPAM Systems Inc NYSE:EPAM from Neutral to Buy. For the first quarter, EPAM Sys had an EPS of $2.49, compared to year-ago quarter EPS of $1.81. At the moment, the stock has a 52-week-high of $725.40 and a 52-week-low of $168.59. EPAM Sys closed at $346.00 at the end of the last trading period.

DZ Bank upgraded the previous rating for Stellantis NV NYSE:STLA from Hold to Buy. NoneAt the moment, the stock has a 52-week-high of $21.99 and a 52-week-low of $13.06. Stellantis closed at $13.42 at the end of the last trading period.

For Hersha Hospitality Trust NYSE:HT, Stifel upgraded the previous rating of Hold to Buy. In the first quarter, Hersha Hospitality showed an EPS of $0.06, compared to $0.36 from the year-ago quarter. At the moment, the stock has a 52-week-high of $12.42 and a 52-week-low of $7.92. Hersha Hospitality closed at $9.96 at the end of the last trading period.

For Pactiv Evergreen Inc NASDAQ:PTVE, RBC Capital upgraded the previous rating of Sector Perform to Outperform. Pactiv Evergreen earned $0.24 in the first quarter, compared to $0.01 in the year-ago quarter. At the moment, the stock has a 52-week-high of $16.49 and a 52-week-low of $8.71. Pactiv Evergreen closed at $10.23 at the end of the last trading period.

For TPI Composites Inc NASDAQ:TPIC, Roth Capital upgraded the previous rating of Neutral to Buy. For the first quarter, TPI Composites had an EPS of $0.71, compared to year-ago quarter EPS of $0.05. The current stock performance of TPI Composites shows a 52-week-high of $52.18 and a 52-week-low of $9.23. Moreover, at the end of the last trading period, the closing price was at $12.36.

Piper Sandler upgraded the previous rating for Boot Barn Holdings Inc NYSE:BOOT from Neutral to Overweight. Boot Barn Holdings earned $2.23 in the third quarter, compared to $0.99 in the year-ago quarter. The current stock performance of Boot Barn Holdings shows a 52-week-high of $134.50 and a 52-week-low of $66.58. Moreover, at the end of the last trading period, the closing price was at $95.77.

See all analyst ratings upgrades.

Downgrades

According to Needham, the prior rating for Bandwidth Inc NASDAQ:BAND was changed from Buy to Hold. In the first quarter, Bandwidth showed an EPS of $0.09, compared to $0.30 from the year-ago quarter. The stock has a 52-week-high of $145.97 and a 52-week-low of $22.00. At the end of the last trading period, Bandwidth closed at $26.74.

For Northwest Bancshares Inc NASDAQ:NWBI, Piper Sandler downgraded the previous rating of Neutral to Underweight. In the first quarter, Northwest Bancshares showed an EPS of $0.22, compared to $0.32 from the year-ago quarter. The current stock performance of Northwest Bancshares shows a 52-week-high of $15.14 and a 52-week-low of $12.33. Moreover, at the end of the last trading period, the closing price was at $12.65.

For BancFirst Corp NASDAQ:BANF, Piper Sandler downgraded the previous rating of Neutral to Underweight. For the first quarter, BancFirst had an EPS of $1.08, compared to year-ago quarter EPS of $1.27. The stock has a 52-week-high of $86.82 and a 52-week-low of $53.77. At the end of the last trading period, BancFirst closed at $84.67.

For Lancaster Colony Corp NASDAQ:LANC, Benchmark downgraded the previous rating of Buy to Hold. Lancaster Colony earned $0.71 in the third quarter, compared to $1.05 in the year-ago quarter. The stock has a 52-week-high of $201.31 and a 52-week-low of $135.82. At the end of the last trading period, Lancaster Colony closed at $139.46.

For Silicon Motion Technology Corp NASDAQ:SIMO, Needham downgraded the previous rating of Buy to Hold. For the first quarter, Silicon Motion Technology had an EPS of $1.72, compared to year-ago quarter EPS of $1.11. The current stock performance of Silicon Motion Technology shows a 52-week-high of $98.65 and a 52-week-low of $58.86. Moreover, at the end of the last trading period, the closing price was at $95.16.

According to Canaccord Genuity, the prior rating for Virgin Galactic Holdings Inc NYSE:SPCE was changed from Buy to Hold. In the first quarter, Virgin Galactic Hldgs showed an EPS of $0.36, compared to $0.55 from the year-ago quarter. The stock has a 52-week-high of $57.51 and a 52-week-low of $6.70. At the end of the last trading period, Virgin Galactic Hldgs closed at $7.50.

For iRobot Corp NASDAQ:IRBT, JP Morgan downgraded the previous rating of Neutral to Underweight. For the first quarter, iRobot had an EPS of $0.66, compared to year-ago quarter EPS of $0.41. At the moment, the stock has a 52-week-high of $106.65 and a 52-week-low of $48.36. iRobot closed at $53.09 at the end of the last trading period.

According to Mizuho, the prior rating for Black Hills Corp NYSE:BKH was changed from Buy to Neutral. Black Hills earned $1.82 in the first quarter, compared to $1.54 in the year-ago quarter. At the moment, the stock has a 52-week-high of $80.95 and a 52-week-low of $61.95. Black Hills closed at $75.34 at the end of the last trading period.

For Ardelyx Inc NASDAQ:ARDX, Cantor Fitzgerald downgraded the previous rating of Overweight to Neutral. For the first quarter, Ardelyx had an EPS of $0.21, compared to year-ago quarter EPS of $0.34. The stock has a 52-week-high of $8.25 and a 52-week-low of $0.58. At the end of the last trading period, Ardelyx closed at $0.84.

According to Roth Capital, the prior rating for FuboTV Inc NYSE:FUBO was changed from Buy to Neutral. FuboTV earned $0.69 in the first quarter, compared to $0.55 in the year-ago quarter. The current stock performance of FuboTV shows a 52-week-high of $35.10 and a 52-week-low of $3.68. Moreover, at the end of the last trading period, the closing price was at $4.12.

For Vapotherm Inc NYSE:VAPO, Canaccord Genuity downgraded the previous rating of Buy to Hold. In the first quarter, Vapotherm showed an EPS of $0.83, compared to $0.40 from the year-ago quarter. At the moment, the stock has a 52-week-high of $31.87 and a 52-week-low of $3.93. Vapotherm closed at $4.48 at the end of the last trading period.

Piper Sandler downgraded the previous rating for Wayfair Inc NYSE:W from Overweight to Neutral. In the first quarter, Wayfair showed an EPS of $1.96, compared to $1.00 from the year-ago quarter. The stock has a 52-week-high of $339.56 and a 52-week-low of $65.32. At the end of the last trading period, Wayfair closed at $67.45.

For Vimeo Inc NASDAQ:VMEO, Piper Sandler downgraded the previous rating of Overweight to Neutral. The stock has a 52-week-high of $58.00 and a 52-week-low of $9.15. At the end of the last trading period, Vimeo closed at $10.37.

According to Stifel, the prior rating for Hanesbrands Inc NYSE:HBI was changed from Buy to Hold. In the first quarter, Hanesbrands showed an EPS of $0.34, compared to $0.39 from the year-ago quarter. The current stock performance of Hanesbrands shows a 52-week-high of $22.82 and a 52-week-low of $12.70. Moreover, at the end of the last trading period, the closing price was at $12.71.

For Ball Corp NYSE:BLL, RBC Capital downgraded the previous rating of Outperform to Sector Perform. Ball earned $0.77 in the first quarter, compared to $0.72 in the year-ago quarter. The current stock performance of Ball shows a 52-week-high of $98.09 and a 52-week-low of $74.13. Moreover, at the end of the last trading period, the closing price was at $76.80.

According to Cantor Fitzgerald, the prior rating for TherapeuticsMD Inc NASDAQ:TXMD was changed from Overweight to Neutral. TherapeuticsMD earned $0.09 in the fourth quarter, compared to $0.15 in the year-ago quarter. At the moment, the stock has a 52-week-high of $1.39 and a 52-week-low of $0.17. TherapeuticsMD closed at $0.17 at the end of the last trading period.

Cantor Fitzgerald downgraded the previous rating for Entasis Therapeutics Holdings Inc NASDAQ:ETTX from Overweight to Neutral. Entasis Therapeutics Hldg earned $0.32 in the first quarter, compared to $0.29 in the year-ago quarter. The stock has a 52-week-high of $3.88 and a 52-week-low of $1.40. At the end of the last trading period, Entasis Therapeutics Hldg closed at $1.89.

According to JP Morgan, the prior rating for Amarin Corp PLC NASDAQ:AMRN was changed from Neutral to Underweight. In the first quarter, Amarin Corp showed an EPS of $0.06, compared to $0.00 from the year-ago quarter. The stock has a 52-week-high of $5.97 and a 52-week-low of $1.34. At the end of the last trading period, Amarin Corp closed at $1.35.

JP Morgan downgraded the previous rating for Corteva Inc NYSE:CTVA from Overweight to Neutral. Corteva earned $0.97 in the first quarter, compared to $0.79 in the year-ago quarter. The current stock performance of Corteva shows a 52-week-high of $62.04 and a 52-week-low of $40.60. Moreover, at the end of the last trading period, the closing price was at $58.04.

According to JP Morgan, the prior rating for FuboTV Inc NYSE:FUBO was changed from Neutral to Underweight. For the first quarter, FuboTV had an EPS of $0.69, compared to year-ago quarter EPS of $0.55. The current stock performance of FuboTV shows a 52-week-high of $35.10 and a 52-week-low of $3.68. Moreover, at the end of the last trading period, the closing price was at $4.12.

See all analyst ratings downgrades.

Initiations

Ladenburg Thalmann initiated coverage on Quoin Pharmaceuticals Ltd NASDAQ:QNRX with a Buy rating. The price target for Quoin Pharmaceuticals is set to $2.00. For the third quarter, Quoin Pharmaceuticals had an EPS of $1.40, compared to year-ago quarter EPS of $0.00. The current stock performance of Quoin Pharmaceuticals shows a 52-week-high of $29.80 and a 52-week-low of $0.78. Moreover, at the end of the last trading period, the closing price was at $0.81.

CICC initiated coverage on FinVolution Group NYSE:FINV with an Outperform rating. The price target for FinVolution Gr is set to $5.63. FinVolution Gr earned $0.37 in the fourth quarter, compared to $0.26 in the year-ago quarter. At the moment, the stock has a 52-week-high of $10.41 and a 52-week-low of $2.68. FinVolution Gr closed at $3.80 at the end of the last trading period.

See all analyst ratings initiations.

More HT News

  • BRIEF-Hersha Hospitality Trust To Sell Non-Core Urban Select Service Properties For $505 Mln
    Reuters - 6:04 AM ET 04/28/2022
  • Hersha Hospitality Trust to Sell Non-Core Urban Select Service Properties for $505 Million
    GlobeNewswire - 6:00 AM ET 04/28/2022
  • BRIEF-Hersha Hospitality Trust Posts Q1 Loss Per Share Of $0.58
    Reuters - 6:00 PM ET 04/27/2022
Fidelity Investments. Copyright 1998–2022 FMR LLC. 
All rights reserved. 

  • Terms of Use|
  • Privacy|
  • Security|
  • Site Map 
Close